Skip to main content
. 2024 Apr 4;271(7):4075–4085. doi: 10.1007/s00415-024-12331-2

Table 1.

Main characteristics of studies (n = 13) included in the systematic review

Study Country Study type Sample Type of stroke
MS stroke +  MS total Control stroke +  Control stroke All-cause stroke AIS ICH
Allen et al. 2008 [18] USA Registry 178 9949 268 19,898  +   +   + 
Christiansen et al. 2010 [19] Denmark Cohort 38 13,963 49 66,407  +   + 
Lavela et al. 2012 [20] USA Cohort 80 1142 957 68,357  + 
Zöller et al. 2012 [21] Sweden Registry 88 10,384  +   +   + 
Jadidi et al. 2013 [22] Sweden Registry 194 7664 728 66,214  + 
Tseng et al. 2014 [23] Taiwan Cohort 41 1174 44 4696  +   + 
Capcun et al. 2015 [24] USA Cohort 1880 15,684 2812 78,420  +   +   + 
Thorman et al. 2016 [25] Denmark Registry 565 8947 1677 44,735  + 
Persson et al. 2017 [26] UK/USA Registry 88 12,132 456 123,612  +   + 
Zulfiqar et al. 2018 [27] Mexico Cohort 107 57,099  + 
Castelo-Branco et al. 2020 [28] Sweden Cohort 159 6602 518 61,828  +   + 
Tadic et al. 2020 [29] Bosnia and Herzegovina Cohort 1 100 2 50  + 
Cho et al. 2022 [30] South Korea Cohort 86 1541 171 7705  +   +   + 

Abbreviations: MS: multiple sclerosis; AIS: acute ischaemic attack; ICH: intracerebral haemorrhage